Windlas Biotech Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹238.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.32 per cent from ₹233.10 crore. This corresponds to a year-on-year *(YoY) growth of 17.66 per cent.
Operating Profit
Operating Profit stands at ₹25.29 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.78 per cent from ₹24.37 crore. This corresponds to a year-on-year *(YoY) decline of 1.02 per cent.
PBDT
PBDT stands at ₹28.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.81 per cent from ₹27.67 crore. This corresponds to a year-on-year *(YoY) decline of 3.43 per cent.
Profit Before Tax
Profit Before Tax stands at ₹20.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.00 per cent from ₹19.97 crore. This corresponds to a year-on-year *(YoY) decline of 3.17 per cent.
Net Profit
Net Profit stands at ₹15.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.60 per cent from ₹15.00 crore. This represents a 1.78 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Windlas Biotech Ltd Earnings
- YOY
- QOQ
Windlas Biotech Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Windlas Biotech Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Windlas Biotech Ltd Financial Reports
Windlas Biotech Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Windlas Biotech | -0.32% | -0.14% | -1.81% | -0.26% | 2.05% | -13.62% |
| Indoco Remedies | 0.48% | -11.38% | -10.22% | 4.15% | -6.53% | -27.57% |
| NGL Fine Chem | -0.08% | 0.93% | 2.65% | 45.19% | 79.05% | 154.11% |
| Ind-Swift Labs. | 2.88% | -6.24% | 5.02% | 65.35% | 98.24% | 115.84% |
| Titan Biotech | -0.77% | 0.80% | 7.48% | -15.71% | 102.19% | 359.36% |
| Fredun Pharma | 4.01% | 8.86% | 14.38% | 22.05% | 81.28% | 191.62% |
| Jagsonpal Pharma | -0.73% | 0.55% | -2.37% | 8.57% | 28.89% | -15.18% |
Company Info
Company Information
Chairman & Independent Directo : Vivek Dhariwal
WTD & Executive Director : ASHOK KUMAR WINDLASS
Joint MD & Executive Director : MANOJ KUMAR WINDLASS
Executive Director & MD : HITESH WINDLASS
Independent Non Exe. Director : Gaurav Gulati
Non Executive Director : Prachi Jain Windlass
Executive Director : Pawan Kumar Sharma
Independent Non Exe. Director : Tarashree Singhal
Company Sec. & Compli. Officer : Ananta Narayan Panda